Literature DB >> 11442757

Modification of fibroblast gamma-interferon responses by extracellular matrix.

A Kern1, K Liu, J Mansbridge.   

Abstract

Fibroblasts from scaffold-based three-dimensional human cultures have been demonstrated to colonize ulcer wound beds and persist for at least 6 mo without rejection. This study examines the expression in these cultures of molecules associated with activation of the immune system in acute rejection. Studies in monolayer cultures showed that fibroblasts expressed CD40 at about 10% of the surface density seen in umbilical vein endothelial cells, whereas HLA-DR was undetectable. In these cultures, both molecules were induced by gamma-interferon. In scaffold-based three-dimensional cultures, however, a majority of the fibroblasts showed little induction of CD40 and HLA-DR in response to gamma-interferon, although HLA class I expression was increased. Fibroblasts re- isolated from the three-dimensional cultures and cultured in monolayers recovered HLA-DR induction in response to gamma-interferon. Fibroblasts cultured in an alternative three-dimensional system using collagen gels showed CD40 and HLA-DR induction by gamma-interferon in the same manner as monolayer cultures. Comparison of phosphorylation of signal transducer and activator of transcription 1 on tyrosine-701 showed it to be similar in monolayer and three-dimensional culture, and phospho-signal transducer and activator of transcription 1 moved into the nucleus. Induction of the class II transcription activator was greatly reduced, however. We propose that interaction of fibroblasts with the fibroblast-derived extracellular matrix is an important modulator of gamma-interferon responsiveness and that this interaction may play a role in the low immunogenicity of allogeneic fibroblasts grown on scaffolds.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11442757     DOI: 10.1046/j.0022-202x.2001.01386.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  6 in total

1.  Tissue engineering of endothelial cells and the immune response.

Authors:  H Methe; E R Edelman
Journal:  Transplant Proc       Date:  2006-12       Impact factor: 1.066

Review 2.  Commercial considerations in tissue engineering.

Authors:  Jonathan Mansbridge
Journal:  J Anat       Date:  2006-10       Impact factor: 2.610

Review 3.  An update and review of cell-based wound dressings and their integration into clinical practice.

Authors:  Austin Pourmoussa; Daniel J Gardner; Maxwell B Johnson; Alex K Wong
Journal:  Ann Transl Med       Date:  2016-12

4.  Implanted neonatal human dermal fibroblasts influence the recruitment of endothelial cells in mice.

Authors:  Susana G Guerreiro; Christoph Brochhausen; Rita Negrão; Mário A Barbosa; Ronald E Unger; C James Kirkpatrick; Raquel Soares; Pedro L Granja
Journal:  Biomatter       Date:  2012 Jan-Mar

5.  Implantation of a three-dimensional fibroblast matrix improves left ventricular function and blood flow after acute myocardial infarction.

Authors:  Hoang M Thai; Elizabeth Juneman; Jordan Lancaster; Tracy Hagerty; Rose Do; Lisa Castellano; Robert Kellar; Stuart Williams; Gulshan Sethi; Monika Schmelz; Mohamed Gaballa; Steven Goldman
Journal:  Cell Transplant       Date:  2009       Impact factor: 4.064

6.  Analysis of allogenicity of mesenchymal stem cells in engraftment and wound healing in mice.

Authors:  Liwen Chen; Edward E Tredget; Chenxiong Liu; Yaojiong Wu
Journal:  PLoS One       Date:  2009-09-22       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.